Background: The n-3 fatty acid status changes during pregnancy and lactation. Plasma leptin concentrations and gene expression have been related to n-3 fatty acids. Objective: To investigate the relation between plasma leptin concentration and the docosahexaenoic acid (22:6n-3) content of plasma phospholipids during early pregnancy and the postpartum period. Design: Leptin (radioimmunoassay) and the phospholipid fatty acid pro®le (capillary gas-liquid chromatography) were measured in plasma of women during two independent longitudinal observational studies. Dietary intake of n-3 fatty acids was also determined. Results: Within the ®rst 10 weeks after the last menstrual period, an almost parallel increase in leptin concentration and the 22:6n-3 content (mgal and % wtawt) of plasma phospholipids was seen (study 1, n 21). During the postpartum period (study 2, n 57), leptin levels decreased quickly, preceding the changes in 22:6n-3 concentrations. During both studies, leptin concentrations did not consistently relate to dietary intake of n-3 fatty acids or to 22:6n-3 concentrations in plasma phospholipids. Before and during early pregnancy (study 1), signi®cant positive associations between leptin levels and the total amount of phospholipid-associated fatty acids were found. No such association was seen during late pregnancy or the postpartum period (study 2). The postpartum decrease in leptin levels did not differ between lactating and non-lactating women. Conclusions: Not the 22:6n-3 content, but the total amount of phospholipid-associated fatty acids was related to plasma leptin concentration, before and during early pregnancy but not during late pregnancy and the postpartum period. Sponsorship: Dutch Organization for Scienti®c Research (NWO, grant no. 904 62 186).
Introduction
Leptin, 16 kDa product of the`obese-gene' (Zhang et al, 1994) , is synthesized in adipose tissue and regarded as a regulator of energy homeostasis. Serum leptin concentrations are strongly associated to body fatness in adults, children and infants Clapp & Kiess, 1998; Considine et al, 1996; Ellis & Nicolson, 1997; Marchini et al, 1998) . During pregnancy, a marked increase in the maternal serum leptin concentration occurs, which is followed by a sharp decrease immediately after delivery (Butte et al, 1997; Hardie et al, 1997; Sattar et al, 1998; Schrubing et al, 1998) . Several studies have demonstrated that, aside from adipose tissue, the human placenta also synthesizes leptin (Masuzaki et al, 1997; Sen Äaris et al, 1997) . Hormones like human chorionic gonadotrophin (hCG), luteinizing hormone (LH), estradiol and insulin may promote leptin release from maternal adipocytes and contribute to the hyperleptinemia (Hardie et al, 1997; Lepercq et al, 1998; Licinio et al, 1998; Sivan et al, 1998) . The exact role of this hyperleptinemia during pregnancy is not understood. It has been proposed that the pregnancy-associated increase in leptin concentration is important for modulating maternal and fetal substrate availability and supply (Chehab, 1997; Mounzih et al, 1998; Schrubing et al, 2000) .
Recently, Cha and Jones (1998) reported that the dietary intake of polyunsaturated fatty acids might increase plasma leptin levels. They found 60% higher leptin concentrations in rats fed ®sh oil or saf¯ower oil relative to rats fed beef tallow. The authors speculated that the consumption of long-chain polyunsaturated fatty acids (LCPUFAs) of the n-3 family especially increases leptin synthesis and secretion. On the other hand, lower plasma leptin concentrations have been found in mice fed diets rich in n-3 LCPUFAs (Hun et al, 1999) . In diabetic women, the combination of waist:hip ratio and dietary intake of docosahexaenoic acid (22:6n-3) accounted for 42% of the variance in plasma leptin concentration (Rojo-Martõ Ânez et al, 2000) . Moreover, the expression of the leptin gene in intra-abdominal adipose tissue of rats seems to be regulated by n-3 fatty acids, particularly by docosahexaenoic acid (Raclot et al, 1997) . These ®ndings indicate an interaction between n-3 LCPUFA metabolism and plasma leptin concentrations.
During the course of pregnancy, the n-3 fatty acid composition of maternal plasma phospholipids changes (Al et al, 1995) . Independent of dietary intake, the proportion of docosahexaenoic acid increases during the ®rst 16 ± 22 weeks of pregnancy and subsequently decreases until delivery (Al et al, 1995; Otto et al, 2000a) . During the postpartum period, the proportion of docosahexaenoic acid decreases further and this decline is even more pronounced in lactating women (Otto et al, 2000b) . We considered it of interest to investigate whether these alterations in docosahexaenoic acid concentrations are related to the changes in plasma leptin levels. For this reason, we conducted this explorative study and investigated the relation between leptin concentrations and the docosahexaenoic acid content of plasma phospholipids in women during pregnancy and lactation.
Methods

Subjects and design
The study subjects were all participants of two independent longitudinal observational studies, designed to investigate the changes in the biochemical essential fatty acid status of women during early pregnancy or the postpartum period (Otto et al, 2000a,b) . These studies were conducted between 1996 and 1999. The Medical Ethics Committee of the University Hospital in Maastricht approved both study protocols, and an informed consent was obtained from all participants. Study 1. To study changes in essential fatty acid status during early pregnancy, women planning to become pregnant were recruited by means of advertisements in local newspapers. Only healthy women, not suffering from any metabolic, cardiovascular, neurological or renal disorder, were enrolled. From the 67 respondents, six women were already pregnant, 11 chose not to participate, 20 dropped out for various reasons (such as lack of motivation or miscarriage) and six did not conceive within the study period. A non-fasting blood sample was collected on the ®rst or second day of each menstrual period. When menstruation did not occur at the expected time, a blood sample was obtained anyway. As a result, blood was collected 4 ± 5 weeks after the ®rst day of the last menstrual period (LMP) and thus approximately 2 ± 3 weeks after conception, when pregnancy was con®rmed. Further sampling time points were 6, 8 and 10 weeks since the beginning of the LMP. Of the 24 women who completed the study, blood samples from 21 subjects were available for the present analysis.
Study 2. For the second study, healthy pregnant women were recruited through midwife practices in the surrounding area of Maastricht. Inclusion criteria were: a pregnancy duration between 36 and 37 weeks since the ®rst day of the LMP and absence of any metabolic, cardiovascular (including hypertension), neurological or renal disorder. In addition, women who used any medication other than multivitamin or iron supplements and those who had a multiple pregnancy were excluded. Of the 68 women enrolled, six did not deliver at term, two received a blood transfusion and three stopped their participation during the postpartum period, leaving data from 57 women for analysis. Of these subjects, 22 choose to bottle-feed their infant (non-lactating group) and 35 breast-fed their child (lactating group). Non-fasting blood samples collected during home visits at study entry, 2 days after delivery and subsequently 1, 2, 4, and 8 weeks after parturition were used during the present study. Four women stopped breastfeeding their infant within this period (three 2 weeks after delivery, one 4 weeks after delivery).
Dietary intake of fatty acids
A food frequency questionnaire (FFQ) was used to assess dietary fatty acid intake as described before Otto et al, 2000a) . Dietary intake was determined twice during study 1. The ®rst FFQ was sent before pregnancy and the second one at the end of the study period. Because there were no major differences in dietary intake between these two measurements (Otto et al, 2000a) , the average intake was calculated and used. During study 2, the dietary intake of fatty acids determined 4 weeks after delivery was used. Because the FFQ was returned incomplete or not returned at all, no intake data was available for eight subjects (one in study 1, seven in study 2).
Blood collection and laboratory analyses
Blood was collected in EDTA-containing tubes at the reported time points. Plasma was separated from blood cells by centrifugation and stored under nitrogen at 780 C until analysis. The fatty acid composition of plasma phospholipids was determined by capillary gas-liquid chromatography as described before (Otto et al, 2000a,b) . Fatty acid concentrations are reported in mgal plasma or as percentage of total fatty acids (% wtawt). Detailed information on the longitudinal changes in the fatty acid pro®le of plasma phospholipids during both study periods have been reported before (Otto et al, 2000a,b) .
Plasma leptin concentration was measured using a commercial human leptin radioimmunoassay kit (Linco Research, St Charles, MO, USA) according to the manufacturer's instructions. To investigate the effect of storage at 780 C and of multiple freeze ± thaw cycles on plasma leptin levels, spare blood samples of 10 pregnant women collected during a previous project were analyzed. After AE 8 y of storage, leptin concentrations were within a physiological range (mean leptin concentration was 18.6 AE 3.3 mgal at 13 weeks since the LMP) and related to both body mass and body mass index (r 0.84, P 0.003 and r 0.82, P 0.007, respectively). Additional cycles of freezing and thawing of these samples did not in¯uence leptin concentrations signi®cantly (not shown). These ®nd-ings indicate that leptin is stable even after a long time of storage at 780 C under our conditions, and con®rm the results of Tamura et al, 1998 , who analyzed serum stored for more than nine years.
Statistical methods
Values are reported as mean AE s.e.m. Within groups, differences between time points were evaluated by paired Student's t-tests. Unpaired Student's t-tests were applied to study differences between groups. Relations between variables were analyzed with simple, multiple and stepwise regression models. Changes in plasma fatty acid levels and leptin concentrations in time were evaluated with repeated measures ANOVA. Differences between lactating and nonlactating women during the postpartum period were examined by the group Â time interaction factor in the repeated measures ANOVA models. Because of a skewed distribution of leptin concentration, natural log-transformed data were used during the analyses when appropriate. A twotailed P-value`0.05 was considered statistically signi®-cant. All statistical analyses were performed using the StatView version 4.5 statistical computer program (Abacus Concepts Inc., Berkeley, CA, USA).
Results
Body weight, body mass index and plasma leptin concentration Age, height, pre-pregnancy weight and pre-pregnancy BMI were similar in both study groups. Body weight and body mass index (BMI) increased during the ®rst 10 weeks of pregnancy (P`0.02). During the postpartum period, body weight and BMI decreased (P`0.001). Postpartum body weight and BMI were slightly higher than the self-reported pregravid values (P`0.001), indicating weight retention. Body weight (not shown) and BMI were positively related to plasma leptin concentration in pregnant women (r 0.70, P`0.0001) and in non-pregnant women (r 0.80, P`0.0001). Mean plasma leptin concentration at study entry was 12.1 AE 1.8 mgal in the non-pregnant women of study 1 and 19.1 AE 1.5 mgal in the pregnant women of study 2. Independent of BMI, plasma leptin concentrations were higher in pregnant women than in nonpregnant women (P`0.0001). In non-lactating women, the amount of weight retained after delivery was positively related to plasma leptin concentrations measured at study entry (r 0.46, P 0.04). This relation was not statistically signi®cant in lactating women.
Plasma leptin concentration and the dietary intake of fatty acids
The dietary intake of n-3 fatty acids, including docosahexaenoic acid, did not signi®cantly differ between the two study populations (not shown). Plasma leptin concentration was negatively related to the intake of n-3 fatty acids (r 70.38, P 0.007) in the women of study 2 only. When studied separately, this negative relation was present in lactating women (r 70.37, P 0.04) but not in nonlactating women (r 0.008, P 0.98). No statistically signi®cant relation was found between plasma leptin levels and the dietary intake of n-3 fatty acids after adjustment for pre-pregnancy BMI.
Leptin concentration and the fatty acid composition of plasma phospholipids Observations during early pregnancy (study 1). The time course of leptin concentration during early pregnancy is shown in Figure 1 . A rapid increase was observed. Leptin concentrations measured 4 weeks after the ®rst day of the LMP were signi®cantly higher than the pre-pregnant values (P 0.02). This observation demonstrates that the increase in leptin levels had already started within the ®rst 2 ± 3 weeks after conception. A similar and almost parallel rapid increase was observed for the docosahexaenoic acid concentration in plasma phospholipids (Figure 1 ). Four weeks after the LMP, both the proportion (% wtawt) and the absolute concentration (mgal) of docosahexaenoic acid were signi®cantly higher than before pregnancy (P 0.02 and P 0.01, respectively). A much slower increase was seen for the total amount of phospholipid-associated fatty acids (Figure 1 ). This increase was signi®cant 10 weeks after the LMP only (P 0.002).
A positive cross-sectional association between leptin concentration and the absolute concentration (mgal) of docosahexaenoic acid in plasma phospholipids was present 6 weeks after the LMP (r 0.55, P 0.008) and 8 weeks after the LMP (r 0.47, P 0.03). Associations at other sampling points were not statistically signi®cant. The proportion of docosahexaenoic acid (% wtawt) in plasma phospholipids did not relate to leptin concentrations at all, neither before pregnancy nor at any other time point. More consistent were the relations between leptin concentration and the total amount of phospholipid-associated fatty acids in plasma (Table 1) . Similar associations were found between the total amount of phospholipid-associated fatty acids and pre-pregnancy BMI (Table 1) . When a stepwise regression procedure was performed, the average amount of total phospholipid-associated fatty acids was predicted by the average leptin concentration (r 2 0.36, P 0.005), displacing average BMI.
Studying the relation between delta leptin concentration (difference between the value at week 10 and the prepregnant value) and delta total phospholipid-associated fatty acids, a weak positive but non-signi®cant association was seen (r 0.38, P 0.09). Similarly, a positive trend between delta phospholipid docosahexaenoic acid concentration (mgal) and delta leptin levels was observed (r 0.38, P 0.09). Delta leptin concentration did not relate to the change in the proportion (% wtawt) of docosahexaenoic acid in plasma phospholipids (r 0.11, P 0.63).
Observations during late pregnancy and the postpartum period (study 2). The time course of leptin concentration during late pregnancy and the postpartum period is shown in Figure 2 . After parturition, leptin concentration decreased quickly. The lowest leptin levels were measured one week after delivery. During the subsequent 3 weeks, leptin levels increased and reached values close to those measured before pregnancy in the women of study 1. A much slower decrease was observed for the total amount of phospholipid-associated fatty acids and the phospholipidesteri®ed docosahexaenoic acid concentrations (mgal and % wtawt) in plasma of women during the postpartum period (Figure 2) .
Unlike in study 1, no signi®cant cross-sectional associations between plasma leptin levels and the total amount of phospholipid-associated fatty acids or the phospholipid docosahexaenoic acid concentrations (mgal and % wtawt) were present. Even when plasma leptin concentrations were stable, 8 weeks after parturition, no association between leptin levels and the total amount of phospholipidassociated fatty acids was seen. Furthermore, no relation was found between the total amount of phospholipidassociated fatty acids and pre-pregnancy BMI either. The associations between leptin concentrations and pre-pregnancy BMI remained, during pregnancy and during the postpartum period (not shown).
As indicated by the time Â group interaction factors of the ANOVA model, the postpartum changes in leptin concentration did not signi®cantly differ between lactating women and non-lactating women. Although leptin concentrations were signi®cantly higher in non-lactating women when compared to lactating women (P 0.0009), this difference was already seen before delivery. Adjustment for this difference in initial leptin concentration did not alter the results. There was still no statistically signi®cant difference in the postpartum change of leptin concentrations between the two groups. Excluding the four women who stopped breast-feeding their infant within the study period did not in¯uence the outcomes either.
The decrease in the proportion (% wtawt) of docosahexaenoic acid was more pronounced in lactating women than in non-lactating women, whereas the changes in the total amount of phospholipid-associated fatty acids and phopholipid docosahexaenoic acid concentration (mgal) did not differ (reported before in Otto et al, 2000b) . Neither the changes in phospholipid docosahexaenoic acid concentrations (mgal and % wtawt) nor the change in the total amount of phospholipid-associated fatty acids were signi®cantly related to the change in plasma leptin levels.
Relations between leptin concentration and other phospholipid-associated fatty acids In rats (Cha & Jones, 1998) and diabetic patients (RojoMartõ Ânez et al, 2000) , leptin concentrations have also been related to other fatty acids than docosahexaenoic acid. Therefore, we also explored potential associations between leptin levels and the proportions (% wtawt) of palmitic acid (16:0), stearic acid (18:0), oleic acid (18:1n-9), linoleic acid (18:2n-6), arachidonic acid (20:4n-6) and eicosapentanoic acid (20:5n-3) in plasma phospholipids. Weak and inconsistent associations were found. In the pregnant women of study 2, leptin concentrations were positively related to the proportion of oleic acid (r 0.31, P 0.02) and negatively to the proportion of linoleic acid (r 70.34, P 0.01), at study entry. This negative relation with linoleic acid concentration was also found two weeks after delivery (r 70.33, P 0.01). At the other time points of measurement, however, no such relations were found.
Discussion
As in many other studies (Butte et al, 1997; Lage et al, 1999; Sattar et al, 1998; Schrubing et al, 1998; Tamura et al, 1998) , plasma leptin concentrations were signi®cantly higher in pregnant women when compared to non-pregnant women. Our study further indicated that this pregnancyrelated increase in leptin concentration starts within the ®rst 2 ± 3 weeks after conception. It is suggested that the placenta is a major source of maternal leptin during pregnancy (Masuzaki et al, 1997; Sen Äaris et al, 1997) . Considering the fast increase in leptin concentration during the ®rst weeks of pregnancy, other sources of leptin might be involved. According to Sivan and colleagues (Sivan et al, 1998) , hormones like human chorionic gonadotropin (produced by the conceptus during early pregnancy) may stimulate the release of leptin from maternal adipocytes and contribute to the hyperleptinemia.
In the present study, plasma leptin concentration was negatively related to the intake of n-3 fatty acids, but only after delivery in lactating women. Although the changes in the phospholipid-esteri®ed docosahexaenoic acid concentration (mgal and % wtawt) almost paralleled those of leptin concentration, they did not seem to be related. Positive associations between concentrations of docosahexaenoic acid and leptin levels were found during early pregnancy, but they were inconsistent and only present when the docosahexaenoic acid concentration was expressed in absolute values (mgal). During early pregnancy, no relation was found between leptin concentration and the proportion of any other investigated fatty acid either. Moreover, neither the fatty acid composition of plasma phospholipids nor the dietary intake of fatty acids were related to leptin levels before the women were pregnant. These ®ndings differ from previous observations in non-pregnant diabetic women (Rojo-Martõ Ânez et al, 2000) .
Interestingly, more consistent relations were found between leptin concentration and the total amount of phospholipid-associated fatty acids during the ®rst 10 weeks of pregnancy. In a stepwise regression analysis, leptin explained 36% of the variance in the total amount of phospholipid-associated fatty acids, displacing body mass index. Except for sphingomyelins, phospholipids generally contain two fatty acid molecules. Unless major changes in the composition of plasma phospholipid classes occur, the total amount of phospholipid-associated fatty acids mainly re¯ects the plasma phospholipid pool size. Therefore, our ®ndings suggest that the phospholipid pool size rather than its composition is either directly or indirectly related to leptin concentrations.
The maternal liver is regarded as the main source of plasma phospholipids and associated fatty acids during pregnancy. Both an increased phospholipid synthesis and an increased release of very low-density lipoprotein (VLDL) particles are considered to be involved (Herrera, 2000; Neville, 1999) . Placenta-derived hormones such as estrogens play an important role in this process (Alverez et al, 1996; Hachey, 1994) . Whether leptin (derived from the placenta or from maternal adipocytes) has any in¯uence on hepatic phospholipid synthesis or VLDL release is unknown and remains to be explored.
The most substantial increases in plasma phospholipids and other lipid fractions occur after the ®rst 10 weeks of pregnancy (Desoye et al, 1987; Potter & Nestel, 1979) . When we studied the relations between pre-pregnancy BMI, leptin concentration and the amount of phospholipid-associated fatty acids at 36 weeks of gestation and during the subsequent postpartum period, the total amount of fatty acids in plasma phospholipids no longer related to either BMI or leptin concentration. It seems that the relation between leptin, BMI and the phospholipid pool size is`uncoupled' during the course of pregnancy. The association between BMI and leptin concentrations, however, remained. An explanation for the lack of an association between leptin concentration and the total amount of phospholipidassociated fatty acids during late pregnancy could be that the women became leptin resistant. Many investigators proposed such a leptin resistant state during pregnancy (Chehab, 1997; Hardie et al, 1997; Highman et al, 1998; Mounzih et al, 1998; Sattar et al, 1998; Schrubing et al, 1997) . They believe that this putative insensitivity to leptin could be of physiologic importance. It would support maternal food intake and the accumulation of fat and nutrient reserves, which are necessary for optimal fetal growth during later phases of pregnancy and for lactation. It is not known whether such a leptin resistant state would support the development of hyperlipidemia during pregnancy, but it has been suggested that leptin resistance might lead to obesity syndromes that share the phenotypes of hypertriglyceridemia, insulin resistance and diabetes (Unger et al, 1999) . The very same phenotypes are common among pregnant women.
A continuation of leptin insensitivity after delivery could explain the lack of an association between leptin levels and the total amount of phospholipid-associated fatty acids during the postpartum period. As proposed by Stein et al (1998) , such a continuation of leptin resistance could also explain the observed weight retention. During the present study, a positive association between leptin concentration at study entry and retained weight after delivery was found in non-lactating women. However, since no clinical test is available to determine leptin resistance, the proposed leptin insensitivity remains speculative.
Leptin is known to circulate in a free as well as a protein-bound form. The RIA-method used during the present study measures the total amount of circulating immunoreactive leptin and does not distinguish between these two forms, unless combined with gel-exclusion chromatography (Teppa et al, 2000) . Recent studies have shown that the concentrations of both forms of circulating leptin are elevated during pregnancy (Lewandowski et al, 1999; Teppa et al, 2000) . Free leptin and bound leptin may have distinct functions (Brabant et al, 2000) . Whether free leptin or bound leptin relates to the plasma phospholipidassociated fatty acids during early pregnancy cannot be derived from our results and thus needs further elucidation. Therefore, it seems advisable to measure both forms of circulating leptin during future studies.
In summary, the total amount of plasma phospholipidassociated fatty acids (rather than the proportion of any speci®c fatty acid such as docosahexaenoic acid) is related to both BMI and leptin concentration, before and during early pregnancy. These associations are no longer present during late pregnancy and the ®rst two months after delivery. Although it seems that leptin is not associated to the pregnancy-related changes in the concentrations of plasma phospholipid-associated fatty acids directly, the involvement of a leptin resistant state during pregnancy cannot be excluded. Figure 2 Leptin concentration, total amount of phospholipid-associated fatty acids and the phospholipid-esteri®ed docosahexaenoic acid (22:6n-3) concentration in plasma of women during the postpartum period (study 2, n 57). Mean pregnancy duration was 36.4AE 0.1 weeks at entry and 40.3AE 0.2 weeks at delivery (D). Because of a skewed distribution of leptin concentrations, natural log-transformed data were used. Values are meanAE s.e.m. The reported P-values indicate a signi®cant change in time (repeated measures ANOVA).
